| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12185-017-2346-6 |
| P698 | PubMed publication ID | 29022209 |
| P50 | author | Irina Kozhukharova | Q57013148 |
| P2093 | author name string | Victoria Zemelko | |
| Nikolay Nikolsky | |||
| Olga Lyublinskaya | |||
| Larisa Alekseenko | |||
| Zoya Kovaleva | |||
| P2860 | cites work | Mesenchymal Stromal Cells and Tissue-Specific Progenitor Cells: Their Role in Tissue Homeostasis | Q26773016 |
| Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression | Q26773413 | ||
| DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139 | Q28131715 | ||
| Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity | Q29614981 | ||
| p53-dependent apoptosis modulates the cytotoxicity of anticancer agents | Q29615031 | ||
| The senescence-associated secretory phenotype: the dark side of tumor suppression | Q29620106 | ||
| Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids | Q58319926 | ||
| Differentiation-related response to DNA breaks in human mesenchymal stem cells | Q64386387 | ||
| Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species | Q74014516 | ||
| Brain-derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood-derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/Akt-dependent signaling pathways | Q81158469 | ||
| ??? | Q62633203 | ||
| Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing | Q33326623 | ||
| A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin | Q33540751 | ||
| Survival responses of human embryonic stem cells to DNA damage | Q34078474 | ||
| H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy. | Q34089263 | ||
| Growth factor regulation of proliferation and survival of multipotential stromal cells | Q34318054 | ||
| Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. | Q34320295 | ||
| Senescence and apoptosis: dueling or complementary cell fates? | Q34619554 | ||
| Multiple facets of histone variant H2AX: a DNA double-strand-break marker with several biological functions | Q35171563 | ||
| Persistent DNA damage-induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells. | Q35390924 | ||
| A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome. | Q37124125 | ||
| Sublethal oxidative stress induces the premature senescence of human mesenchymal stem cells derived from endometrium | Q37156197 | ||
| Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. | Q37345878 | ||
| Doxorubicin: the good, the bad and the ugly effect | Q37528487 | ||
| gammaH2AX: a sensitive molecular marker of DNA damage and repair | Q37687078 | ||
| Brain-derived neurotrophic factor attenuates doxorubicin-induced cardiac dysfunction through activating Akt signalling in rats | Q37693349 | ||
| Neurotrophin regulation of neural circuit development and function | Q38068714 | ||
| Doxorubicin Affects Expression of Proteins of Neuronal Pathways in MCF-7 Breast Cancer Cells | Q38400621 | ||
| BMSCs and hematopoiesis | Q38550689 | ||
| Senescence as a general cellular response to stress: A mini-review | Q38598950 | ||
| Sublethal heat shock induces premature senescence rather than apoptosis in human mesenchymal stem cells. | Q38687525 | ||
| Doxorubicin induces the DNA damage response in cultured human mesenchymal stem cells. | Q39257323 | ||
| DNMT3a plays a role in switches between doxorubicin-induced senescence and apoptosis of colorectal cancer cells | Q39703300 | ||
| Tissue-specific Differentiation Potency of Mesenchymal Stromal Cells from Perinatal Tissues | Q39863008 | ||
| Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. | Q40195961 | ||
| The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis | Q40300478 | ||
| Evaluation of chemosensitivity of human bone marrow stromal cells--differences between common chemotherapeutic drugs. | Q40316982 | ||
| Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks | Q40593721 | ||
| Suppression of adriamycin-induced apoptosis by sustained activation of the phosphatidylinositol-3'-OH kinase-Akt pathway | Q40624347 | ||
| Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function | Q41883542 | ||
| Reactive Oxygen Species Are Required for Human Mesenchymal Stem Cells to Initiate Proliferation after the Quiescence Exit | Q42141820 | ||
| High basal γH2AX levels sustain self-renewal of mouse embryonic and induced pluripotent stem cells | Q42506988 | ||
| Doxorubicin has in vivo toxicological effects on ex vivo cultured mesenchymal stem cells. | Q42708123 | ||
| Irradiation of adult human dental pulp stem cells provokes activation of p53, cell cycle arrest, and senescence but not apoptosis. | Q43121021 | ||
| Caspase inhibition switches doxorubicin-induced apoptosis to senescence | Q44438871 | ||
| Doxorubicin caused apoptosis of mesenchymal stem cells via p38, JNK and p53 pathway. | Q45929499 | ||
| Transdifferentiation of bone marrow stromal cells into cholinergic neuronal phenotype: a potential source for cell therapy in spinal cord injury | Q46104110 | ||
| Activation of DNA damage response signaling in mouse embryonic stem cells | Q46372405 | ||
| Neuronal differentiation potential of human adipose-derived mesenchymal stem cells. | Q46531960 | ||
| Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage | Q46887314 | ||
| Effects of high-dose chemotherapy on bone marrow multipotent mesenchymal stromal cells isolated from lymphoma patients. | Q54442482 | ||
| Doxorubicin induces senescence and impairs function of human cardiac progenitor cells. | Q54449632 | ||
| P921 | main subject | menstruation | Q12171 |
| doxorubicin | Q18936 | ||
| P577 | publication date | 2017-10-11 | |
| P1433 | published in | International Journal of Hematology | Q6051416 |
| P1476 | title | Therapeutic doses of doxorubicin induce premature senescence of human mesenchymal stem cells derived from menstrual blood, bone marrow and adipose tissue |
| Q89657824 | Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments |
| Q98178384 | Development of Natural-Based Bone Cement for a Controlled Doxorubicin-Drug Release |
| Q61801033 | High doses of synthetic antioxidants induce premature senescence in cultivated mesenchymal stem cells |
| Q93147053 | Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate |
| Q61455264 | Quiescent Human Mesenchymal Stem Cells Are More Resistant to Heat Stress than Cycling Cells |
| Q96954753 | Three-Dimensional Compaction Switches Stress Response Programs and Enhances Therapeutic Efficacy of Endometrial Mesenchymal Stem/Stromal Cells |
Search more.